According to Sana Biotechnology's latest financial reports the company's current EPS (TTM) is -0,76 โฌ. In 2024 the company made an earnings per share (EPS) of -1,00 โฌ an increase over its 2023 EPS that were of -1,26 โฌ.
Year | EPS | Change |
---|---|---|
2025 (TTM) | -0,82 โฌ | -18.46% |
2024 | -1,00 โฌ | -20.82% |
2023 | -1,26 โฌ | 2.45% |
2022 | -1,23 โฌ | -42.34% |
2021 | -2,14 โฌ | 26.08% |
2020 | -1,70 โฌ |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | -1,61 โฌ | 112.50% | ๐บ๐ธ USA |